莊輝院士:為什么指南不推薦TAF預防HBV母嬰傳播( 三 )


15.ZengQL,ZhangHX,ZhangJY,etal.TenofoviralafenamideforpregnantChinesewomenwithactivechronichepatitisB:Amulticenterprospectivestudy.ClinGastroenterolHepatol,2022,20(12):2826-2837.e9.
16.DingY,CaoL,ZhuL,etal.Efficacyandsafetyoftenofoviralafenamidefumarateforpreventingmother-to-childtransmissionofhepatitisBvirus:anationalcohortstudy.AlimentPharmacolTher,2020,52(8):1377-1386.
17.HanG,ZhouG,SunT,etal.Tenofoviralafenamideinblockingmother-to-childtransmissionofhepatitisBvirus:amulti-center,prospectivestudy.JMaternFetalNeonatalMed,2022,1-8.
#****#3往期推薦
肝病年會丨莊輝院士:中國肝病的疾病負擔
肝病年會丨韓濤教授:肝衰竭診治的進展與挑戰
肝病年會丨范建高教授:《肝硬化合并糖尿病患者血糖管理專家共識》解讀
肝病年會丨《慢性乙型肝炎防治指南(2022年版)》更新要點詳解返回搜狐 , 查看更多
責任編輯: